Old Web
English
Sign In
Acemap
>
authorDetail
>
Qiangfang Cao
Qiangfang Cao
Cancer
Cancer research
Autophosphorylation
Tyrosine kinase
Vandetanib
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract B01: BLU-667: A highly selective RET inhibitor to target RET-driven NSCLC
2018
Clinical Cancer Research
Rami Rahal
Michelle Maynard
Wei Hu
Jason D. Brubaker
Qiangfang Cao
Joseph L. Kim
Michael P. Sheets
Douglas Wilson
Kevin J. Wilson
Lucian Dipietro
Timothy P. LaBranche
Beni B. Wolf
Timothy J. Guzi
Christoph Lengauer
Erica K. Evans
Show All
Source
Cite
Save
Citations (0)
Abstract B01: BLU-667: A highly selective RET inhibitor to target RET-driven NSCLC
2018
Clinical Cancer Research
Rami Rahal
Michelle Maynard
Wei Hu
Jason D. Brubaker
Qiangfang Cao
Joseph L. Kim
Michael P. Sheets
Douglas Wilson
Kevin J. Wilson
Dipietro Lucian
Timothy P. LaBranche
Beni B. Wolf
Timothy J. Guzi
Christoph Lengauer
Erica K. Evans
Show All
Source
Cite
Save
Citations (0)
1